1. No sanctions for Novartis as FDA ends review of gene therapy violations— Medtronic makes plans for a ventilator open-source— COVID could cause 'digital reset' for pharma — See more on our front page news Stay updated with the latest pharma-related coronavirus news on our new page
    Dismiss Notice
  2. Think you have witnessed fraud?Ask a Whistleblower Attorney -- a chance to discuss whistleblower-related legal issues with practicing whistleblower attorneys.
    Dismiss Notice

Any insight on Desai's departure?

Discussion in 'Apotex' started by anonymous, Jan 29, 2018 at 9:41 AM.

Tags: Add Tags
  1. anonymous

    anonymous Guest

    Anyone have any insights on why Desai departed on Friday?
     

  2. anonymous

    anonymous Guest